OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
[Corrigendum] Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3‑kinase inhibitor (ZSTK474)	142
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer	109
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)	101
Identification and characterization of slow‑cycling cells in Ewing sarcoma	60
[Retracted] Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway	60
From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)	59
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells	55
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)	54
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes	54
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m⁶₂A and CD) regulations on patients with cancer and healthy individuals	53
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer	48
Role of miR‑181a‑5p in cancer (Review)	47
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways	43
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma	40
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol	40
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin	39
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A20	38
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors	35
[Retracted] Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma	33
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression	32
[Retracted] Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis	30
[Retracted] MicroRNA‑155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2	30
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells	29
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)	29
Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response	28

Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)	28
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)	28
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells	27
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)	26
[Corrigendum] HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3	26
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer	26
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression	26
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer	25
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)	25
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)	25
[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation	25
Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)	24
Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway	24
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer	24
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)	23
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation	23
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review)	23
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization	23
Application of cfDNA methylation in cancer prognostic assessment: Progress and challenges (Review)	23
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway	22
[Retracted] miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1	22
[Expression of Concern] Establishment and evaluation of a new highly metastatic tumor cell line 5a‑D‑Luc‑ZsGreen expressing both luciferase and green fluorescent protein	22
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4	22
[Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells	22
lncRNA AL445238.2‑USP4 axis regulates cell survival and stemness in colon cancer	22
An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)	21
[Retracted] MicroRNA‑181a regulates epithelial‑mesenchymal transition by targeting PTEN in drug‑resistant lung adenocarcinoma cells	21
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)	21
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells	21
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer	20
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma	20
GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF‑1/SREBP‑1	20
Role of miRNA‑122 in cancer (Review)	20
The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells	20
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)	20
Role of DCLK1 in oncogenic signaling (Review)	19
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)	19
Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review)	19
[Expression of Concern] MicroRNA‑195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways	19
[Corrigendum] Podoplanin‑mediated TGF‑β‑induced epithelial‑mesen‑ chymal transition and its correlation with bHLH transcription factor DEC in TE‑11 cells	19
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer	19
Ferroptosis in biliary tract cancer: Molecular mechanisms and therapeutic applications (Review)	19
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway	18
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3	18
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells	18
LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myeloma	18
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway	18
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)	18
Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)	18
[Retracted] NR4A1‑induced increase in the sensitivity of a human gastric cancer line to TNFα‑mediated apoptosis is associated with the inhibition of JNK/Parkin‑dependent mitophagy	18

[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma	17
[Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma	17
Antitumor effect of memantine is related to the formation of the splicing isoform of GLG1, a decoy FGF‑binding protein	17
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway	17
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9	17
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)	17
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionality	17
CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review)	17
[Retracted] Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion	17
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells	16
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer	16
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells	16
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α	16
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)	16
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review)	16
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer	16
Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review)	16
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway	15
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)	15
[Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration	15
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome	15
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia	15
[Corrigendum] Leptin promotes breast cancer cell migration and invasion via IL‑18 expression and secretion	15
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)	15
[Expression of Concern] Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells	15
Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling	14
[Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis	14
Roles of salt‑inducible kinases in cancer (Review)	14
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer	14
Targeting drug resistance in glioblastoma (Review)	14
Circular RNAs in osteosarcoma: An update of recent studies (Review)	14
MicroRNA in adenoid cystic carcinoma (Review)	14
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)	14
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)	14
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma	13
[Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase‑9	13
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling	13
Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer	13
[Retracted] Expression and function of PIM kinases in osteosarcoma	13
Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review)	13
Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer	13
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells	13
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway	13
m⁶A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling	13
[Retracted] lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma	13
Research advances in aptamers in the diagnosis and treatment of breast cancer (Review)	13
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells	12
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation	12
IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review)	12
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)	12
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia	12
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)	12
Function of microRNA‑124 in the pathogenesis of cancer (Review)	12
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma	12
[Corrigendum] The mechanism of adenosine‑mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells	12
ZBTB20 promotes ferroptosis through inhibiting TMEM109 expression in glioblastoma cells	12
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation	12
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer	12
Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway	11
New insights into lipid metabolism and prostate cancer (Review)	11
Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H	11
[Retracted] Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF‑7 breast cancer cells	11
Role of microRNAs in glycolysis in gynecological tumors (Review)	11
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)	11
Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review)	11
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance	11
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion	11
P2Y₂R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells	11
Tumor suppressive functions of WNT5A in rhabdomyosarcoma	11
Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review)	11
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer	11
mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review)	11
[Corrigendum] STAT3 activation in HER2‑overexpressing breast cancer promotes epithelial‑mesenchymal transition and cancer stem cell traits	11
[Retracted] Matrix metalloproteinase‑1 promotes prostate tumor growth and metastasis	11
KMO downregulation promotes hepatocellular carcinoma growth via 3‑HAA‑mediated mitochondrial mass and function imbalances	11
Smoking promotes colorectal cancer via the CKAP2L/AREG axis	11
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation	10
[Retracted] MicroRNA‑30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHR	10
[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles	10
Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine	10

[Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway	10
[Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids	10
Altered expression of the IGF2‑H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma	10
Hyperthermia reduces cancer cell invasion and combats chemoresistance and immune evasion in human bladder cancer	10
Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model	10
Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)	10
Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review)	10
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion	10
S100 protein family: Emerging role and mechanism in digestive tract cancer (Review)	9
Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review)	9
Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment	9
Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review)	9
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway	9
Adjusting for comorbidity in observational cancer studies: A systematic review to assess alignment between index and study	9
Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review)	9
[Retracted] SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non‑small cell lung cancer cells through deacetylation of NMNAT2	9
Role of N⁶‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)	9
SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma	9
[Corrigendum] The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells	9
Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway	9
The apelin‑apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells	9
Advances in the study of the breast carcinoma exosomal microRNAs: from basic mechanisms to clinical applications (Review)	9
Molecular targets of primary cilia defects in cancer (Review)	9
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway	9
Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)	8
[Expression of Concern] Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin‑like growth factor 2 imprinting	8
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer	8
[Retracted] Silencing the long noncoding RNA, TINCR , a molecular sponge of miR‑335 , inhibits the maligna	8
Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER⁺ breast cancer cells	8
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review)	8
Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review)	8
Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells	8
Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9	8
The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review)	8
[Retracted] SRF‑miR‑29b‑MMP2 axis inhibits NSCLC invasion and metastasis	8
RNA binding proteins in extracellular vesicles and their potential value for cancer diagnosis and treatment (Review)	8
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)	8
Diverse roles of SERPINE1 in regulating cellular proliferation and invasion	8
A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer	8
Notch3 mediated TGF‑β1 activation enhances epithelial‑mesenchymal transition and cancer stemness in non‑small lung cancer	8
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review)	8
Targeting ferroptosis in Helicobacter pylori ‑associated gastric cancer development: From molecular mechanisms to application prospects (Review)	7
[Retracted] Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma	7
Pancreatic cancer EMT‑targeted therapy: Molecular mechanisms and clinical translation (Review)	7
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review)	7
[Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway	7
Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review)	7
Immunomodulatory antitumor effect of interferon‑beta combined with gemcitabine in pancreatic cancer	7
Role of histone modifications in gastric cancer (Review)	7
A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M2	7
Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization	7
A perspective on the chemical structures and molecular mechanisms of curcumin and its derivatives and analogs in cancer treatment (Review)	7
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer	7
Selective antitumor and apoptosis‑inducing effects of the Src inhibitor PP1 in human tongue squamous cell carcinoma cells	7
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation	7
DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells	7
Enolase 1: A paradigm of metabolic enzyme moonlighting in tumorigenesis (Review)	7
RNA‑binding protein DAZAP1 promotes gastric cancer metastasis by enhancing NOTCH1 and JAG1 mRNA stability	7
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway	7
MicroRNA‑21: A potential therapeutic target in lung cancer (Review)	7
Roles of m⁶A modification in oral cancer (Review)	7
Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR‑124/SIRT1 axis in cervical cancer cells	7
Beyond the membrane: Internalization and compartmentalization of insulin‑like growth factor 1 receptor signaling in cancer pathogenesis and treatment (Review)	7
[Retracted] uPAR and cathepsin B knockdown inhibits radiation‑induced PKC integrated integrin signaling to the cytoskeleton of glioma‑initiating cells	6
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)	6
Synergistic and toxicity‑reducing effects of acteoside as an adjuvant therapy of oxaliplatin against hepatocellular carcinoma	6
Decoding the role of cancer stem cells in digestive tract tumors: Mechanisms and therapeutic implications (Review)	6
[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth	6
Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑7	6
Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review)	6
CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells	6
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)	6
N⁶‑methyladenosine‑induced long non‑coding RNA PVT1 regulates the miR‑27b‑3p/BLM axis to promote prostate cancer progression	6
Targeting neddylation as a novel approach to lung cancer treatment (Review)	6
HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer	6
Long non‑coding RNAs in multiple myeloma (Review)	6
[Expression of Concern] AHIF promotes glioblastoma progression and radioresistance via exosomes	6
Discovery of the late autophagy inhibitor FZU‑0045‑053 and its anti‑breast cancer and immunomodulatory effects	5
Progerin regulates actin cytoskeletal remodeling and inhibits EMT and metastasis in triple‑negative breast cancer cells	5
Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification	5
Heterogeneity of primary and metastatic CAFs: From differential treatment outcomes to treatment opportunities (Review)	5
Realgar‑induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis	5
[Retracted] MicroRNA‑488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3	5
Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway	5
[Corrigendum] Furin promotes epithelial‑mesenchymal transition in pancreatic cancer cells via Hippo‑YAP pathway	5
[Corrigendum] Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer	5
Research progress on immunotherapy in triple‑negative breast cancer (Review)	5
Role and underlying mechanisms of miR‑200 family in breast cancer (Review)	5
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)	5
PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review)	5
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA	5
Emerging roles of RNA m6A modification in multiple myeloma pathogenesis and treatment resistance (Review)	5
The EDN1/EDNRA/β‑arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation	5
[Retracted] miR‑486 suppresses the development of osteosarcoma by regulating PKC‑δ pathway	5
Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review)	5